Our diligence is pretty extensive. It’s about a 60-day process. We have a dual path of both business and legal diligence. From a business standpoint, once the internal review’s over and we made a decision to go forward, we engage an outside group of... Read more
I spent my career representing companies that were raising capital and funds that were investing capital in those companies. And, I think the key thing that was the light bulb that came on for me, for iSelect, and what was the fundamental discovery that gave... Read more
Neuros Medical, part of the iSelect healthcare portfolio since 2016, closed a $20 million Series AA financing round, led by U.S. Venture Partners and joined by iSelect, Boston Scientific, Aperture Venture Partners, Osage University Partners, and JumpStart, Inc. Neuros... Read more
I was in Phoenix recently meeting with some prospective investors. At the end of the dinner presentation, I sat with a table of younger investors and we started talking about genomics, CRISPR and 23andMe. Then the floodgates opened… These young people not only... Read more
Last weekend I was in Grayling, Michigan for the famous canoe marathon, a 14-hour, non-stop race through the night. The Ausable, known as the Holy Waters, is a beautiful river with many naturally fallen trees, obstacles, and tight bends. Given the obstructions, some... Read more
